Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2Gynecologic 2Lymphoid 1

Conditions

Lung Neoplasms 3642Carcinoma, Non-Small-Cell Lung 3583Small Cell Lung Carcinoma 576Breast Neoplasms 419Neoplasms 299Adenocarcinoma of Lung 248Colorectal Neoplasms 222Melanoma 201Mesothelioma, Malignant 183Pancreatic Neoplasms 179Prostatic Neoplasms 178Brain Neoplasms 178Head and Neck Neoplasms 172Neoplasm Metastasis 167Ovarian Neoplasms 153Esophageal Neoplasms 152Mesothelioma 145Colonic Neoplasms 140Stomach Neoplasms 139NSCLC 115Pleural Effusion, Malignant 114Carcinoma, Renal Cell 109Urinary Bladder Neoplasms 105Disease 96Sarcoma 85Uterine Cervical Neoplasms 82Thymoma 79Liver Neoplasms 77Motor Activity 75Squamous Cell Carcinoma of Head and Neck 72

Interventions

Tomography, X-Ray Computed 1Spirometry 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × HIV Seropositivity × Thoracic × Clear all
NCT01296113 2023-03-14

CHIVA

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Completed
61 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, HIV Seropositivity

NCT01748136 2019-03-28

NA_00036809

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Completed
200 enrolled
Thoracic

HIV Seropositivity, Lung Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡